Primary Hepatic Leiomyosarcoma: A Case Series Highlighting a Rare Malignancy

IF 3.3 Q2 GASTROENTEROLOGY & HEPATOLOGY
Divya Khosla , Treshita Dey , Rakesh Kapoor , Suvradeep Mitra , Divyesh Kumar , Shikha Goyal , Renu Madan , Kimavat Hemanth Kumar , Rajesh Gupta
{"title":"Primary Hepatic Leiomyosarcoma: A Case Series Highlighting a Rare Malignancy","authors":"Divya Khosla ,&nbsp;Treshita Dey ,&nbsp;Rakesh Kapoor ,&nbsp;Suvradeep Mitra ,&nbsp;Divyesh Kumar ,&nbsp;Shikha Goyal ,&nbsp;Renu Madan ,&nbsp;Kimavat Hemanth Kumar ,&nbsp;Rajesh Gupta","doi":"10.1016/j.jceh.2025.102602","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Primary hepatic leiomyosarcoma (PHLMS) is an exceedingly rare malignant tumor originating from the liver with only a handful of cases reported in literature. Herein, we present five cases of PHLMS diagnosed and managed at our institute.</div></div><div><h3>Results</h3><div>The patients presented with non-specific symptoms, e.g., abdominal pain, lump, jaundice, etc., and imaging showed a space-occupying lesion in the liver. Hence, histopathological examination plays a pivotal role in diagnosis, revealing characteristic features of spindle-shaped cells arranged in fascicles or bundles with high mitotic rate and varying degrees of necrosis. Only 1 out of 5 patients underwent surgery. The remaining patients were planned with either palliative chemotherapy or best supportive care based on their performance status. The prognosis is however poor in such patients.</div></div><div><h3>Conclusion</h3><div>Despite aggressive management, prognosis of PHLMS remains guarded. Surgical resection is the backbone of a radical treatment. This case series presents a rare entity providing insights into the diagnosis, management, and prognosis of the patients with PHLMS.</div></div>","PeriodicalId":15479,"journal":{"name":"Journal of Clinical and Experimental Hepatology","volume":"15 6","pages":"Article 102602"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0973688325001021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Primary hepatic leiomyosarcoma (PHLMS) is an exceedingly rare malignant tumor originating from the liver with only a handful of cases reported in literature. Herein, we present five cases of PHLMS diagnosed and managed at our institute.

Results

The patients presented with non-specific symptoms, e.g., abdominal pain, lump, jaundice, etc., and imaging showed a space-occupying lesion in the liver. Hence, histopathological examination plays a pivotal role in diagnosis, revealing characteristic features of spindle-shaped cells arranged in fascicles or bundles with high mitotic rate and varying degrees of necrosis. Only 1 out of 5 patients underwent surgery. The remaining patients were planned with either palliative chemotherapy or best supportive care based on their performance status. The prognosis is however poor in such patients.

Conclusion

Despite aggressive management, prognosis of PHLMS remains guarded. Surgical resection is the backbone of a radical treatment. This case series presents a rare entity providing insights into the diagnosis, management, and prognosis of the patients with PHLMS.
原发性肝平滑肌肉瘤:一个罕见恶性肿瘤的病例系列
目的原发性肝平滑肌肉瘤(PHLMS)是一种极为罕见的起源于肝脏的恶性肿瘤,文献报道病例很少。在此,我们报告了在我院诊断和治疗的5例PHLMS病例。结果患者表现为腹痛、肿块、黄疸等非特异性症状,影像学表现为肝脏占位性病变。因此,组织病理学检查在诊断中起关键作用,揭示纺锤形细胞呈束状或束状排列,有丝分裂率高,不同程度坏死的特征。5名患者中只有1人接受了手术。其余患者根据其表现状况计划姑息性化疗或最佳支持性护理。然而,这些患者的预后很差。结论尽管积极治疗,但PHLMS的预后仍值得关注。手术切除是根治性治疗的基础。本病例系列提供了一个罕见的实体,为PHLMS患者的诊断,管理和预后提供了见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical and Experimental Hepatology
Journal of Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.90
自引率
16.70%
发文量
537
审稿时长
64 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信